SELLAS Life Sciences Group Current Deferred Revenue (Quarterly) Insights

SELLAS Life Sciences Group, Inc. (SLS)

3.30 -0.05 (-1.49%) USD | NASDAQ | Dec 30, 16:00

3.31 +0.01 (+0.30%) After-Hours: 18:41

View Current Deferred Revenue (Quarterly) for SLS.
Upgrade now.

Sep '18

Jan '19

May '19

285.00

270.00

255.00

240.00

View Current Deferred Revenue (Quarterly) Chart

Start Trial

View Historical Data

Start Trial

View Current Deferred Revenue (Quarterly) Range, Past 5 Years

Start Trial

Minimum

Maximum

Average

Median

View Current Deferred Revenue (Quarterly) Benchmarks

Start Trial

GT Biopharma, Inc.	--
Geron Corp.	--
ADMA Biologics, Inc.	Upgrade
Lyell Immunopharma, Inc.	--
NovaBay Pharmaceuticals, Inc.	--